We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Top Buys

Rank Stock Value
1
PLAY icon
Dave & Buster's
PLAY
+$2.84M
2
LYV icon
Live Nation Entertainment
LYV
+$2.81M
3
WWW icon
Wolverine World Wide
WWW
+$2.72M
4
TSLA icon
Tesla
TSLA
+$2.63M
5
CALY
Callaway Golf Company
CALY
+$2.58M

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$3.61M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.99M
3
EXTR icon
Extreme Networks
EXTR
+$2.33M
4
CASY icon
Casey's General Stores
CASY
+$2.21M
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
626
Pliant Therapeutics
PLRX
$65M
$464K 0.06%
22,235
-50,818
-70% -$972K
TRIP icon
627
TripAdvisor
TRIP
$1.26B
$463K 0.06%
+20,962
New +$470K
TILE icon
628
Interface
TILE
$2.22B
$462K 0.06%
51,413
+36,384
+242% +$440K
WH icon
629
Wyndham Hotels & Resorts
WH
$5.48B
$462K 0.06%
+7,524
New +$504K
CPF icon
630
Central Pacific Financial
CPF
$1B
$461K 0.06%
22,292
+374
+2% +$8.43K
INGR icon
631
Ingredion
INGR
$6.58B
$461K 0.06%
5,726
-7,968
-58% -$699K
AMZN icon
632
Amazon
AMZN
$2.96T
$459K 0.06%
+4,060
New +$513K
MBIO icon
633
Mustang Bio
MBIO
$4.55M
$459K 0.06%
1,303
+76
+6% +$35.2K
BAC icon
634
Bank of America
BAC
$442B
$458K 0.06%
15,170
-18,527
-55% -$619K
BARK icon
635
BARK
BARK
$101M
$458K 0.06%
12,584
-3,081
-20% -$114K
COO icon
636
Cooper Companies
COO
$14.5B
$458K 0.06%
+6,948
New +$532K
LKFN icon
637
Lakeland Financial Corp
LKFN
$1.53B
$458K 0.06%
+6,289
New +$469K
RXDX
638
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$458K 0.06%
+7,765
New +$355K
GSM icon
639
FerroAtlántica
GSM
$839M
$457K 0.06%
86,586
+19,758
+30% +$122K
NTAP icon
640
NetApp
NTAP
$37.2B
$457K 0.06%
7,390
-7,061
-49% -$491K
ORLY icon
641
O'Reilly Automotive
ORLY
$76.3B
$456K 0.06%
+9,735
New +$454K
TSHA icon
642
Taysha Gene Therapies
TSHA
$1.89B
$456K 0.06%
236,120
+49,640
+27% +$180K
XRN
643
Chiron Real Estate Inc
XRN
$477M
$455K 0.06%
10,678
-8,654
-45% -$477K
LFUS icon
644
Littelfuse
LFUS
$11.6B
$455K 0.06%
2,288
-698
-23% -$167K
INTU icon
645
Intuit
INTU
$89B
$454K 0.06%
1,173
+517
+79% +$223K
IDT icon
646
IDT Corp
IDT
$1.62B
$453K 0.06%
+18,226
New +$468K
COUP
647
DELISTED
Coupa Software Incorporated
COUP
$450K 0.06%
+7,657
New +$502K
DRE
648
DELISTED
Duke Realty Corp.
DRE
$450K 0.06%
+9,335
New +$547K
AEM icon
649
Agnico Eagle Mines
AEM
$90.5B
$449K 0.06%
10,626
-2,942
-22% -$126K
ICE icon
650
Intercontinental Exchange
ICE
$84.4B
$449K 0.06%
+4,972
New +$499K
24 25
26
27 28

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.